Iterum Therapeutics plc - Ordinary Share (ITRM)
0.0300
+0.00 (0.00%)
NASDAQ · Last Trade: May 6th, 8:16 PM EDT
Detailed Quote
| Previous Close | 0.0300 |
|---|---|
| Open | - |
| Bid | 0.0308 |
| Ask | 0.0320 |
| Day's Range | N/A - N/A |
| 52 Week Range | 0.0271 - 1.280 |
| Volume | 0 |
| Market Cap | 391.23K |
| PE Ratio (TTM) | -0.0423 |
| EPS (TTM) | -0.7 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | - |
Chart
About Iterum Therapeutics plc - Ordinary Share (ITRM)
Iterum Therapeutics is a biopharmaceutical company focused on developing innovative antibacterial therapies to combat serious infections caused by multidrug-resistant bacteria. The company harnesses its expertise in microbiology and drug development to advance its therapeutic candidates through clinical trials, aiming to provide effective treatment options for patients with limited choices due to rising antibiotic resistance. With a commitment to addressing urgent public health challenges, Iterum Therapeutics is dedicated to delivering next-generation antibiotics that can improve patient outcomes and enhance global health. Read More
News & Press Releases
Top movers in Tuesday's after hours sessionchartmill.com
Via Chartmill · March 31, 2026
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.chartmill.com
Via Chartmill · March 31, 2026
American Lithium Minerals (OTC: AMLM) continues to broaden its multi-commodity footprint with the acquisition of the Higginsville Gold Project in Western Australia, adding exposure to one of the world’s most prolific gold-producing regions as the company advances its strategy across critical minerals and precious metals .
Via AB Newswire · March 31, 2026
On Tuesday, there are stocks with unusual volume. Let's take a look.chartmill.com
Via Chartmill · March 31, 2026
Which stocks are experiencing notable movement on Tuesday?chartmill.com
Via Chartmill · March 31, 2026
The market is filled with gapping stocks in Tuesday's session.chartmill.com
Via Chartmill · March 31, 2026
Discover the top movers in Tuesday's pre-market session.chartmill.com
Via Chartmill · March 31, 2026
Which stocks are experiencing notable movement on Monday?chartmill.com
Via Chartmill · March 30, 2026
Curious about the most active stocks on Monday?chartmill.com
Via Chartmill · March 30, 2026
Here are the top movers in Monday's session.chartmill.com
Via Chartmill · March 30, 2026
A group of sub-$0.10 and low-priced small-cap stocks is drawing increased attention as investors rotate into high-beta, low-float names across biotechnology, artificial intelligence, and critical minerals . With volatility rising and capital flowing into speculative growth themes, several companies are emerging on trader and investor watchlists.
Via AB Newswire · March 30, 2026
Wondering what's happening in today's pre-market session?chartmill.com
Via Chartmill · March 30, 2026
Friday's after hours session: top gainers and loserschartmill.com
Via Chartmill · March 27, 2026
Top stock movements in today's session.chartmill.com
Via Chartmill · March 27, 2026
Keep an eye on the top gainers and losers in Friday's session.chartmill.com
Via Chartmill · March 27, 2026
Which stocks are gapping on Friday?chartmill.com
Via Chartmill · March 27, 2026
These stocks are moving in today's after hours sessionchartmill.com
Via Chartmill · March 3, 2026
What's going on in today's sessionchartmill.com
Via Chartmill · March 3, 2026
These stocks are moving in today's sessionchartmill.com
Via Chartmill · March 3, 2026
Which stocks are gapping on Tuesday?chartmill.com
Via Chartmill · March 3, 2026
Which stocks are moving before the opening bell on Tuesday?chartmill.com
Via Chartmill · March 3, 2026
Wondering what's happening in today's after-hours session?chartmill.com
Via Chartmill · December 31, 2025
Via Benzinga · November 18, 2025
Iterum Therapeutics (ITRM) Earnings Transcript
Via The Motley Fool · November 14, 2025
Iterum Therapeutics stock plunges after Q3 2025 earnings miss estimates, with a wider-than-expected loss overshadowing its new product launch.
Via Chartmill · November 14, 2025